0000911916-16-000689.txt : 20161107 0000911916-16-000689.hdr.sgml : 20161107 20161107162427 ACCESSION NUMBER: 0000911916-16-000689 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161104 FILED AS OF DATE: 20161107 DATE AS OF CHANGE: 20161107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CoLucid Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001348649 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203419541 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 222 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 781-365-2596 MAIL ADDRESS: STREET 1: 222 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Colucid Pharmaceuticals Inc DATE OF NAME CHANGE: 20060104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hogan Linda C. CENTRAL INDEX KEY: 0001639972 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37358 FILM NUMBER: 161978417 MAIL ADDRESS: STREET 1: 15 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2016-11-04 0001348649 CoLucid Pharmaceuticals, Inc. CLCD 0001639972 Hogan Linda C. C/O COLUCID PHARMACEUTICALS, INC. 222 THIRD STREET CAMBRIDGE MA 02142 0 1 0 0 Head, Bus. Dev. and Strategy Common Stock 2016-11-04 4 M 0 185 7.56 A 185 D Common Stock 2016-11-04 4 S 0 185 28.95 D 0 D Common Stock 2016-11-07 4 M 0 1677 10.00 A 1677 D Common Stock 2016-11-07 4 S 0 1677 28.5212 D 0 D Stock Option (Right to Buy) 7.56 2016-11-04 4 M 0 185 0 D 2025-08-04 Common Stock 185 6112 D Stock Option (Right to Buy) 10.00 2016-11-07 4 M 0 1677 0 D 2025-05-05 Common Stock 1677 50321 D Securities sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Ms. Hogan on March 24, 2016. Represents the sale of 1,677 shares in multiple transactions, ranging in price from $28.50 to $28.60 per share, resulting in a weighted average sale price of $28.5212. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Options vest as follows: one-third of the shares vested on August 4, 2016; and the remaining shares vest in a series of 36 successive equal monthly installments upon completion of each additional month of service. Options vest as follows: 33% of the shares vested on May 5, 2016; and the remaining shares vest in a series of 36 successive equal monthly installments upon completion of each additional month of service. /s/ Christine G. Long, Attorney-in-Fact for Linda C. Hogan (power of attorney previously filed) 2016-11-07